BE873092A - Composition pour le traitement de l'hypertension - Google Patents

Composition pour le traitement de l'hypertension

Info

Publication number
BE873092A
BE873092A BE192574A BE192574A BE873092A BE 873092 A BE873092 A BE 873092A BE 192574 A BE192574 A BE 192574A BE 192574 A BE192574 A BE 192574A BE 873092 A BE873092 A BE 873092A
Authority
BE
Belgium
Prior art keywords
hypertension
treatment
composition
Prior art date
Application number
BE192574A
Other languages
English (en)
French (fr)
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25343256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE873092(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of BE873092A publication Critical patent/BE873092A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BE192574A 1977-12-27 1978-12-27 Composition pour le traitement de l'hypertension BE873092A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86442877A 1977-12-27 1977-12-27

Publications (1)

Publication Number Publication Date
BE873092A true BE873092A (fr) 1979-06-27

Family

ID=25343256

Family Applications (1)

Application Number Title Priority Date Filing Date
BE192574A BE873092A (fr) 1977-12-27 1978-12-27 Composition pour le traitement de l'hypertension

Country Status (30)

Country Link
JP (1) JPS54110333A (no)
AR (1) AR230378A1 (no)
AU (1) AU526239B2 (no)
BE (1) BE873092A (no)
CA (1) CA1120400A (no)
CH (1) CH642542A5 (no)
DE (1) DE2854316C3 (no)
DK (1) DK578778A (no)
EG (1) EG14178A (no)
FI (1) FI783991A (no)
FR (1) FR2413089A1 (no)
GB (1) GB2010675B (no)
GR (1) GR72951B (no)
HK (1) HK45483A (no)
HU (1) HU178747B (no)
IE (1) IE48306B1 (no)
IL (1) IL56281A (no)
IT (1) IT1202811B (no)
KE (1) KE3235A (no)
LU (1) LU80709A1 (no)
MY (2) MY8300240A (no)
NL (2) NL192870C (no)
NO (1) NO784357L (no)
NZ (1) NZ189159A (no)
PH (1) PH22111A (no)
PL (1) PL212188A1 (no)
PT (1) PT68983A (no)
SE (1) SE445173B (no)
SG (1) SG41482G (no)
ZA (1) ZA786948B (no)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344949A (en) 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4350704A (en) 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4482725A (en) * 1980-04-03 1984-11-13 E. R. Squibb & Sons, Inc. S-Acylation products of mercaptoacyl amino acids and carboxyl group containing diuretics
US4532342A (en) * 1981-02-20 1985-07-30 Warner-Lambert Company N-substituted amino acids as intermediates in the preparation of acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
WO1996024358A1 (en) * 1995-02-10 1996-08-15 G.D. Searle & Co. Use of low dose amount of spironolactone for treatment of cardiovascular disease

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5829950B2 (ja) * 1978-10-05 1983-06-25 ウェルファイド株式会社 環状イミノカルボン酸誘導体およびその塩類
US4552889A (en) * 1983-06-09 1985-11-12 Eli Lilly And Company 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
DE3532036A1 (de) * 1985-09-09 1987-03-26 Hoechst Ag Pharmazeutische zubereitung zur behandlung des bluthochdrucks
DK9200258U4 (da) * 1992-03-11 1993-07-23 Merck & Co Inc Farmaceutisk præparat indeholdende enalapril til brug mod hypertension

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU509899B2 (en) * 1976-02-13 1980-05-29 E.R. Squibb & Sons, Inc. Proline derivatives and related compounds

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4482725A (en) * 1980-04-03 1984-11-13 E. R. Squibb & Sons, Inc. S-Acylation products of mercaptoacyl amino acids and carboxyl group containing diuretics
US4344949A (en) 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4350704A (en) 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4532342A (en) * 1981-02-20 1985-07-30 Warner-Lambert Company N-substituted amino acids as intermediates in the preparation of acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
WO1996024358A1 (en) * 1995-02-10 1996-08-15 G.D. Searle & Co. Use of low dose amount of spironolactone for treatment of cardiovascular disease

Also Published As

Publication number Publication date
PH22111A (en) 1988-06-01
AR230378A1 (es) 1984-04-30
CA1120400A (en) 1982-03-23
NZ189159A (en) 1984-12-14
GB2010675A (en) 1979-07-04
NL980017I1 (nl) 1998-07-01
IE782413L (en) 1979-06-27
AU4204178A (en) 1979-07-05
IT7831266A0 (it) 1978-12-22
NL7812164A (nl) 1979-06-29
IE48306B1 (en) 1984-12-12
PT68983A (en) 1979-01-01
IL56281A (en) 1983-05-15
KE3235A (en) 1982-11-05
NL192870C (nl) 1998-04-02
AU526239B2 (en) 1982-12-23
MY8300240A (en) 1983-12-31
DE2854316A1 (de) 1979-07-05
GR72951B (no) 1984-01-17
NL192870B (nl) 1997-12-01
CH642542A5 (de) 1984-04-30
ZA786948B (en) 1980-04-30
HU178747B (en) 1982-06-28
FI783991A (fi) 1979-06-28
DK578778A (da) 1979-06-28
JPS54110333A (en) 1979-08-29
SE7813277L (sv) 1979-06-28
EG14178A (en) 1984-06-30
DE2854316C3 (de) 1994-12-22
IL56281A0 (en) 1979-03-12
SE445173B (sv) 1986-06-09
GB2010675B (en) 1982-06-16
NO784357L (no) 1979-06-28
HK45483A (en) 1983-10-28
SG41482G (en) 1985-01-11
LU80709A1 (de) 1979-04-13
FR2413089B1 (no) 1980-12-26
PL212188A1 (no) 1980-02-11
IT1202811B (it) 1989-02-09
MY102991A (en) 1993-03-31
FR2413089A1 (fr) 1979-07-27
DE2854316C2 (no) 1989-08-10
JPS647045B2 (no) 1989-02-07

Similar Documents

Publication Publication Date Title
BE851328A (fr) Composition pour le traitement de l'hypercholesterolemie
BE859817A (fr) Compositions notamment utiles pour le traitement de l'acne
FR2338687A1 (fr) Endoscope pour le traitement de strictions uretrales
BE890648A (fr) Compositions pour le traitement de l'acne
FR2342072A1 (fr) Composition enzymatique pour le traitement de la cataracte
FR2512669B1 (fr) Composition pour traitement capillaire
FR2340122A1 (fr) Composition anti-moussage pour le traitement de denrees alimentaires
BE890433A (fr) Composition cosmetique pour le traitement local de la cellulite
FR2307909A1 (fr) Compositions pour le traitement des etoffes
BE873092A (fr) Composition pour le traitement de l'hypertension
BE851775A (fr) Composition pour le traitement de la chevelure
BE850383A (fr) Procede ameliore pour le dosage de l'alcoolemie
MA20655A1 (fr) Compositions pour le traitement de textiles
BE858692A (fr) Composition pour le traitement de l'acne
BE872908A (fr) Compositions pharmaceutiques pour le traitement de l'hypertension
FR2340737A1 (fr) Composition pour le traitement de l'hypercholesterolemie
FR2558372B1 (fr) Composition medicamenteuse pour le traitement de l'acne
FR2536995B1 (fr) Composition pour le traitement de l'arthrite
BE856740A (fr) Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
BE856957A (fr) Electrode pour traitement d'ionophorese
BE863085A (fr) Nouvelle composition, en particulier pour le traitement de la cellulite
RO65965A2 (ro) Compozitie medicamentoasa pentru tratamentul ulcerului gastroduodenal
BE842389A (fr) Composition pharmaceutique pour le traitement de l'hyperuricemie
FR2517203B1 (fr) Composition pour le traitement de l'acne
BE864979A (fr) Compositions pour le traitement des etats asthmatiques

Legal Events

Date Code Title Description
CCPA Application for a supplementary protection certificate

Free format text: 093C0035

CCPV Grant of a supplementary protection certificate

Free format text: 093C0035, EXPIRES 19991025

RE20 Patent expired

Owner name: E.R. SQUIBB & SONS INC.

Effective date: 19981227